Physician Assistant, Medical · Grenville, SC
NPI
1336545227
Since 2014
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Bon Secours Endocrinology, 2 Innovation Drive, Ste 300b
Grenville, SC, 29607
Phone (864) 400-3680
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,203 services
Medicare patients, 2024
217
Average age 72
Drug cost, 2024
$3.3M
4,846 prescriptions
Company payments, 2025
$8,762
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leslie Rumbaut was code 99214 (office e&m - established), 420 times for 205 patients. In total Leslie Rumbaut billed 1,203 services in 8 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 420 | 205 | $71.65 | $30K |
| 95251 Test - Miscellaneous | Office | 292 | 134 | $20.13 | $5,879 |
| 83036 Blood Count | Office | 272 | 151 | $9.41 | $2,559 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 156 | 96 | $9.45 | $1,474 |
| 99215 Office E&M - Established | Office | 42 | 35 | $107.13 | $4,499 |
| 99204 Office E&M - New | Office | 11 | 11 | $61.99 | $682 |
By year: 2022 $41K for 889 services; 2023 $45K for 1,042 services; 2024 $45K for 1,203 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 272 | 151 | $9.41 | $2,559 |
Medicare prescription drug claims, 2024
In 2024, the drug Leslie Rumbaut prescribed most often to Medicare patients was Ozempic (Semaglutide), with 327 prescriptions and refills. In total Leslie Rumbaut wrote 4,846 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 327 | 615 | 87 | $587K |
| Levothyroxine Sodium Generic | 263 | 702 | 76 | $2,670 |
| Mounjaro Tirzepatide | 260 | 436 | 55 | $466K |
| Tresiba Flextouch U-200 Insulin Degludec | 252 | 588 | 74 | $336K |
| Novolog Flexpen Insulin Aspart | 221 | 511 | 86 | $75K |
| Jardiance Empagliflozin | 214 | 515 | 62 | $297K |
| Farxiga Dapagliflozin Propanediol | 181 | 401 | 52 | $214K |
| Metformin Hcl Er Metformin Hcl | 175 | 509 | 59 | $1,891 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 175 | 439 | 84 | $26K |
| Humalog Kwikpen U-100 Insulin Lispro | 170 | 406 | 67 | $60K |
| Metformin Hcl Generic | 167 | 491 | 57 | $1,505 |
| Trulicity Dulaglutide | 131 | 234 | 37 | $224K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 131 | 325 | 46 | $24K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 101 | 227 | 28 | $116K |
| Synthroid Levothyroxine Sodium | 99 | 207 | 25 | $8,601 |
Brand drugs: 3,104 claims; generic drugs: 1,198 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leslie Rumbaut $8,762 ($8,762 in general payments such as food, travel and fees) from 11 companies. The largest payer was Dexcom, Inc. with $5,259.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 10 | $5,259 |
| CeQur Corporation | 3 | $1,695 |
| Medtronic, Inc. MDT | 5 | $577 |
| Abbott Laboratories ABT | 3 | $284 |
| Novo Nordisk Inc NVO | 3 | $260 |
| Insulet Corporation PODD | 5 | $206 |
| Ascensia Diabetes Care Us Inc. | 2 | $131 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $122 |
| Sequel Med Tech, LLC | 2 | $93.61 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $77.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.